Catalyst Wire Dossier Catalyst Wire Dossier

INM-755 (cannabinol) cream

cannabinol · InMed Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INM-755 (cannabinol) cream, covering 2023-07-03 to 2023-07-03. Get the full timeline:

Most recent: Clinical Trial Update: INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa [Phase 2]

See pricing